Asherman's syndrome medical therapy

Asherman's syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Asherman's syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Asherman's syndrome medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Asherman's syndrome medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Asherman's syndrome medical therapy
CDC on Asherman's syndrome medical therapy
Asherman's syndrome medical therapy in the news
Blogs on Asherman's syndrome medical therapy
Directions to Hospitals Treating Asherman's syndrome
Risk calculators and risk factors for Asherman's syndrome medical therapy

Editor(s)-in-Chief: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Canan S Fornusek, Ph.D.; Associate Editor-In-Chief: Saud Khan M.D.

Overview

Medical therapy usually follows surgical removal of fibrous bands in the uterus causing the condition. Estrogen provides stimulation for endometrial proliferation.

Medical Therapy

Hormonal therapy with synthetic or conjugated estrogen is usually prescribed following surgery to stimulate endometrial growth thereby preventing the walls of the uterus from re-adhering.

More studies are needed to evaluate which method of treatment is most likely to have a successful outcome.

References

Template:WikiDoc Sources